They found that CYP2A6 protein was very heterogeneous in tumor cells and HCC do not uniformly overexpress the CYP2A6 protein, suggesting that increased expression of CYP2A6 occurred in a distinct subpopulation of neoplastic cells. The gene discussed is CYP2A6; the disease is hepatocellular carcinoma.